MedPath

Standard Treatment Or topical doxepin against Pruritus in burn patients.

Recruiting
Conditions
pruritus, jeukburns, brandwonden
Registration Number
NL-OMON25795
Lead Sponsor
Association of Dutch Burn Centres
Brief Summary

1. Demling R, DeSanti L, Nelson R. Pruritus and burn wound. Wounds 2002;14:2A-7A. <br> 2. Demling R, DeSanti L. Topical doxepin significantly decreases itching and erythema in the chronically pruritic burn scar. Wounds 2003;15(6):195-200.

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
108
Inclusion Criteria

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

1. Patients with healed burns and itch;

Exclusion Criteria

An eligible subject who meets any of the following criteria will be excluded from participation in this study:

1. Inability to give informed consent by patient or legal representatives;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate whether doxepin hydrochloride 5% cream is more effective in reducing pruritus in patients with burns than standard treatment.
Secondary Outcome Measures
NameTimeMethod
To evaluate whether patients treated with doxepin hydrochloride 5% cream compared to standard treatment:<br /><br>1. Have a better quality of life;<br /><br>2. Have less erythematous scars.
© Copyright 2025. All Rights Reserved by MedPath